Delivery Order SPE2DB20D2104-SPE2DB22FS35N
Award Date 4/8/22
Potential Completion Date 4/11/22
Potential Value $2.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $64,041.34 Firm Fixed Price delivery order is for GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,495.70 Firm Fixed Price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,254.54 firm fixed-price delivery order contract is for the provision of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,967.39, is for the delivery of the drug GEMTESA 75 MG TABLET 90S. It is a firm fixed-price delivery order contract with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $12,099.32 Delivery Order contract is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through May 6, 2024 and uses a Firm Fixed Price pricing type. This award is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, worth $39,303.04, is a firm fixed price delivery order for the pharmaceutical product GEMTESA 75 MG TABLET 90S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GEMTESA 75 MG TABLET 90S. The $63,843.93 fixed-price delivery order contract has a completion date of July 17, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,059.45 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 23, 2023 and was awarded on October 20, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,183.78, is a delivery order contract for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,422.28 firm fixed-price delivery order contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a period of performance through December 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...